EFFECTIVENESS OF ROMIPLOSTIM ON PLATELET ENDPOINTS AMONG PATIENTS WITH NEWLY DIAGNOSED, PERSISTENT AND CHRONIC IMMUNE THROMBOCYTOPENIA IN ROUTINE CLINICAL PRACTICE IN DENMARK, SWEDEN, AND NORWAY

EHA Library, Christian Fynbo Christiansen, 324848

OFF-LABEL USE OF ELTROMBOPAG IN A PEDIATRIC POPULATION WITH NEWLY-DIAGNOSED/PERSISTENT IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Giulia Ceglie, 324849

CLINICAL-PATHOLOGICAL PREDICTORS OF SPLENECTOMY RESPONSE IN PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTI-CENTER ITALIAN STUDY.

EHA Library, Marco Pizzi, 324851

TREATMENT OF IMMUNE THROMBOCYTOPENIA IN THE COVID-19 ERA: FOSTAMATINIB, AN ORAL SPLEEN TYROSINE KINASE INHIBITOR

EHA Library, Nichola Cooper, 324852

APPLICATION OF HIGH-THROUGHPUT SEQUENCING TO IDENTIFY COPY NUMBER VARIATIONS IN INHERITED PLATELET DISORDERS

EHA Library, Sandra Santos, 324853

CLINICAL APPLICATION OF GENETIC TESTING IN PATIENTS WITH NOT ACQUIRED THROMBOCYTOPENIA: ONE CENTER EXPERIENCE

EHA Library, Pablo Silva de Tena, 324854

COGNITIVE IMPAIRMENT IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Camelia Vladescu, 324855

EFFECTIVENESS AND SAFETY OF ROMIPLOSTIM AMONG PATIENTS WITH NEWLY DIAGNOSED, PERSISTENT AND CHRONIC ITP IN ROUTINE CENTRAL AND EASTERN EUROPEAN CLINICAL PRACTICE: AN ANALYSIS OF THE PLATON STUDY

EHA Library, Barbara Skopec, 324856

UNUSUAL LABORATORY FEATURES AND CLINICAL COURSE OF HEPARIN INDUCED THROMBOCYTOPENIA IN CARDIOPULMONARY PATIENTS.

EHA Library, Manzoor Mangi, 324857

CAPLACIZUMAB FOR ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA: A SINGLE-INSTITUTION EXPERIENCE

EHA Library, Constantine Logothetis, 324858

BICYTOPENIA AND PANCYTOPENIA IN NEONATES: PREVALENCE, RISK FACTORS, AND OUTCOME

EHA Library, Hale Ören, 324859

IMMUNE THROMBOCYTOPENIA AND COVID-19: A SINGLE CENTRE EXPERIENCE

EHA Library, Marta Moreno Carbonell, 324860

PHARMACOKINETIC EVALUATION OF ELTROMBOPAG IN A COHORT OF PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA

EHA Library, Francesca de Gennaro, 324861

EFFICACY OF THROMBOPOIETIN RECEPTOR AGONISTS IN EVANS SYNDROME: A SINGLE CENTER SERIES

EHA Library, Nicola Cecchi, 324862

ELTROMBOPAG PLUS RHTPO VERSUS ELTROMBOPAG FOR ITP DURING THE COVID-19 PANDEMIC (ELABORATE-19)

EHA Library, Zhuo-Yu An, 324863

IMMUNE THROMBOCYTOPENIA ASSOCIATED WITH LYMPHOID MALIGNANCIES: REPORT FROM A FRENCH PROSPECTIVE REGISTER.

EHA Library, Sylvain Audia, 324864

A MULTICENTER U.S. STUDY OF AVATROMBOPAG SWITCH THERAPY FOLLOWING PRIOR ELTROMBOPAG OR ROMIPLOSTIM

EHA Library, Hanny Al-Samkari, 324865

EPIDEMIOLOGY, TREATMENT PATTERNS, AND CLINICAL OUTCOMES AMONG PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP) IN THE UNITED STATES: AN ELECTRONIC HEALTH RECORDS ANALYSIS

EHA Library, Ayoade Adeyemi, 324866

STYDY OF FAS, CASPASE-8 (CASP8) AND -10 (CASP10) POLYMORPHISMS IN CHILDREN AND ADOLESCENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Evangelia-Dimitra Ampazoglou, 324867

DARATUMUMAB, AN ORIGINAL APPROACH FOR TREATING REFRACTORY AUTOIMMUNE CYTOPENIA

EHA Library, Etienne Crickx, 324868

DURABILITY OF PLATELET COUNT RESPONSE IN PATIENTS TREATED WITH AVATROMBOPAG FOR IMMUNE THROMBOCYTOPENIA (ITP): POST-HOC RESULTS FROM THE PHASE 3 CORE AND OPEN-LABEL EXTENSION STUDY

EHA Library, Michael Vredenburg, 324869

SERUM COMPLEMENT LEVELS IN IMMUNE THROMBOCYTOPENIA: RELATION WITH CLINICAL PRESENTATION AND TREATMENT RESPONSE.

EHA Library, Sandra Pérez-León, 324870

GEOGRAPHIC DISTRIBUTION OF PATIENT AND PHYSICIAN ITP TREATMENT PREFERENCES AND EFFECT OF PHYSICIAN CASELOAD ON TREATMENT PRACTICES: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH)

EHA Library, Nichola Cooper, 324871

LENGTH OF THROMBOPOIETIN RECEPTOR AGONIST (TPO-RA) TREATMENT AND PERSISTENCE IN IMMUNE THROMBOCYTOPENIA (ITP): REAL WORLD UNITED STATES CLAIMS ANALYSES

EHA Library, Michael Vredenburg, 324872

IMMUNE THROMBOCYTOPENIA DURING COVID-19 PANDEMIC: AN ITALIAN MONOCENTRIC EXPERIENCE

EHA Library, Gianfranco Lapietra, 324873

IMPACT OF AUTOIMMUNE ANTIBODIES IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: REAL WORLD RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY

EHA Library, Charalampos Pontikoglou, 324874

SLEEP HEALTH IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: QUALITY OF LIFE DATA FROM THE PLATELET DISORDER SUPPORT ASSOCIATION (PDSA) PATIENT REGISTRY

EHA Library, Jennifer DiRaimo , 324875

ASSOCIATION OF IMMUNE THROMBOCYTOPENIA AND INFLAMMATORY BOWEL DISEASE IN CHILDREN

EHA Library, Angela Guarina, 324876

DEVELOPMENT AND VALIDATION OF THE C-SCORE, A SCORE OF DIAGNOSIS A SEVERE THROMBOCYTOPENIA OR OTHER CYTOPENIAS IN HEPATIC CIRRHOSIS

EHA Library, Felix Gibrant Marquez Villegas, 324877

EFFECTIVENESS AND SAFETY OF ROMIPLOSTIM IN PATIENTS WITH NEWLY DIAGNOSED, PERSISTENT AND CHRONIC PRIMARY IMMUNE THROMBOCYTOPENIA IN GERMAN ROUTINE CLINICAL PRACTICE: THE OBSERVATIONAL PLATEAU STUDY

EHA Library, Marcel Reiser, 324878

ASSOCIATION OF IMMUNE THROMBOCYTOPENIA AND COELIAC DISEASE IN CHILDREN

EHA Library, Angela Guarina, 324879

EPIDEMIOLOGY AND MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN ADULT PATIENTS IN ALGERIA

EHA Library, Mohamed Amine Bekadja, 324880

THE CLINICAL UTILITY OF ALINITY HQ STANDARD AND RESEARCH CBC PARAMETERS IN THE DIFFERENTIAL DIAGNOSIS OF ITP

EHA Library, Sang Mee Hwang, 324881

CHANGES IN THE EXPRESSION OF PROTEINS INVOLVED IN THE CA2+ HOMEOSTASIS IN NEONATE PLATELETS.

EHA Library, Pedro C Redondo, 324882

PERSISTENT CLINICALLY IMPORTANT OUTCOMES OF FATIGUE, NEUROPATHY AND PROBLEMS WITH DAILY FUNCTIONING AMONG INDOLENT NON-HODGKIN LYMPHOMA SURVIVORS.

EHA Library, Afke Ekels, 324883

QUALITY OF LIFE WITH REGN5458 IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PATIENT-REPORTED OUTCOMES (PROS) FROM THE FIRST-IN-HUMAN PHASE 1/2 TRIAL

EHA Library, Naresh Bumma, 324884

LOCAL SAFETY STANDARDS FOR INVASIVE PROCEDURES (LOCSSIPS) IN HAEMATOLOGY

EHA Library, Zeba Ahmed, 324885

SYSTEMATIC LITERATURE REVIEW (SLR) OF THE EFFICACY AND SAFETY OF SECOND-LINE (2L) TREATMENTS FOR RELAPSED OR REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL)

EHA Library, Fei Fei Liu, 324886

ERECTILE DYSFUNCTION (ED) IN PATIENTS WITH LIGHT-CHAIN AMYLOIDOSIS (AL): DIAGNOSIS AND CORRELATION WITH THE HEMATOLOGIC DISEASE.

EHA Library, Claudia Giordano, 324887

COST-EFFECTIVENESS ANALYSIS OF AXICABTAGENE CILOLEUCEL VS TISAGENLECLEUCEL FOR THE MANAGEMENT OF DIFFUSE LARGE B-CELL LYMPHOMA IN SPAIN

EHA Library, Carlos Pardo, 324888

IMPLEMENTATION OF A HOSPITAL-AT-HOME (HAH) UNIT FOR HEMATOLOGICAL PATIENTS DURING THE COVID-19 PANDEMIC: SAFENESS AND FEASIBILITY.

EHA Library, Ignacio Gómez-Centurión, 324889

USE OF CHIMERIC ANTIGEN RECEPTOR T CELL THERAPIES IN PATIENTS WITH LARGE B-CELL LYMPHOMA IN THE REAL-WORLD SETTING: SYSTEMATIC LITERATURE REVIEW

EHA Library, Fei Fei Liu, 324890

OUR EXPERIENCE OF NEGATIVE SYNERGISM BETWEEN STEROIDS AND LMWH IN PATIENTS WITH AGGRESSIVE LNH ON SKELETAL EVENTS (BONE FRACTURES)

EHA Library, Luca Pezzullo, 324891

LANDSCAPE REVIEW OF THE PATIENT-REPORTED OUTCOMES VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) IN ONCOLOGY: ADOPTION AND RECENT LEARNINGS

EHA Library, Antoine Regnault, 324892

THE PSYCHOSOCIAL IMPACT OF HAEMATOPOIETIC STEM CELL TRANSPLANTATION ON ADULT PATIENTS WITH LYMPHOMA, LEUKAEMIA OR MYELODYSPLASTIC SYNDROMES – A LITERATURE REVIEW

EHA Library, Pauline Frank, 324893

COST EFFECTIVENESS COMPARISON OF BELANTAMAB MAFODOTIN AND SELINEXOR IN RELAPSED REFRACTORY MULTIPLE MYELOMA

EHA Library, ANKIT KANSAGRA, 324894

COST-EFFECTIVENESS OF ZANUBRUTINIB VERSUS IBRUTINIB IN ADULT PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Jorge Castillo, 324895

QUANTIFYING PATIENT PREFERENCES FOR TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA: A DISCRETE-CHOICE EXPERIMENT

EHA Library, Bradley Mason, 324896

A NEW OPTION IN PAIN PREVENTION WITH BLISS©, A THERAPEUTIC VIRTUAL REALITY SOLUTION IN BONE MARROW CONTEXT: RESULTS OF A FRENCH OPEN-LABEL MULTICENTER RANDOMIZED PHASE II/III STUDY (REVEH TRIAL)

EHA Library, Katell Le Dû, 324897

A CROSS-SECTIONAL STUDY EXAMINING THE IMPACT OF AGEING ON THE PSYCHOSOCIAL EXPERIENCES OF PATIENTS WITH LYMPHOMA

EHA Library, Natalie Dren, 324898

TARGETED LANDSCAPE REVIEW FOR UNDERSTANDING LYMPHOMA PATIENT-REPORTED OUTCOME ASSESSMENT IN THE ERA OF EMERGING THERAPIES

EHA Library, Stacie Hudgens, 324899

CLINICALLY IMPORTANT CHANGE IN FACIT-FATIGUE SCORE FOR PATIENTS WITH COLD AGGLUTININ DISEASE: AN ANALYSIS USING THE PHASE 3 CARDINAL AND CADENZA STUDIES

EHA Library, Quentin A Hill, 324900

INCREASED ANTIDEPRESSANT USE AMONG NEWLY DIAGNOSED PATIENTS WITH COLD AGGLUTININ DISEASE COMPARED WITH OTHER PATIENTS IN A LARGE US HEALTHCARE SYSTEM

EHA Library, Catherine M Broome, 324901

A MACHINE LEARNING APPROACH TO IDENTIFICATION OF CLINICALLY RELEVANT HEMATOLOGY-ONCOLOGY RESEARCH PUBLICATIONS

EHA Library, Alexander Luchinin, 324902

HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS (PTS) WITH MYELODYSPLASTIC SYNDROMES (MDS) IN THE CONNECT® MYELOID DISEASE REGISTRY

EHA Library, Dennis A. Revicki, 324903

PROSPECTIVE COMPARISON OF POINT-OF-CARE INR VERSUS PLASMA INR IN SUPRA-THERAPEUTIC INR VALUES

EHA Library, Maria Angustias Molina Arrebola, 324904

FERTILITY PRESERVATION IN LYMPHOMA PATIENTS TREATED WITH IMMUNOCHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY: RESULTS OF A RETROSPECTIVE MULTICENTER STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FERTY CARE).

EHA Library, Ombretta Annibali, 324905

IMPACT OF THE COVID-19 PANDEMIC ON HEALTH-RELATED QUALITY OF LIFE AND ANXIETY IN PEDIATRIC HEMATOLOGY/ONCOLOGY PATIENTS: A SINGLE EGYPTIAN CENTER EXPERIENCE

EHA Library, Yasmine El Chazli, 324906

THE IMPACT OF COVID-19 ON A RURAL HEMATOLOGY OUTREACH SERVICE, AN AUSTRALIAN EXPERIENCE

EHA Library, Helen Cashman, 324907

APPRAISAL OF THE CONSISTENT USE AND REPORTING OF PATIENT-REPORTED OUTCOMES IN MULTIPLE MYELOMA CLINICAL TRIALS: DOES IT MATTER?

EHA Library, Edward Laane, 324908

FERTILITY ANALYSIS IN MALE PATIENTS LONG SURVIVING BY HODGKIN'S LYMPHOMA

EHA Library, Francesco Gaudio, 324909

IMPACT OF COVID-19 ON AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN MULTIPLE MYELOMA (MM) PATIENTS: A SINGLE-CENTRE, QUALITATIVE EVALUATION STUDY

EHA Library, Marquita Camilleri, 324910

OUTCOMES OF BRENTUXIMAB VEDOTIN AS ≥3 LINE TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: PHYSICIAN’S AND PATIENT’S PERSPECTIVE

EHA Library, Tatyana Ionova, 324911

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA’S HUMANISTIC AND ECONOMIC BURDEN IN PATIENTS RECEIVING C5 INHIBITORS IN EUROPE

EHA Library, Jens Panse, 324912

DEVELOPING TREATMENT ATTRIBUTES FOR A PATIENT PREFERENCE SURVEY: A QUALITATIVE MULTINATIONAL STUDY IN MULTIPLE MYELOMA

EHA Library, Rosanne Janssens, 324913

HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH COLD AGGLUTININ DISEASE IN DENMARK

EHA Library, Emese Vágó, 324914

THE LIFETIME ECONOMIC BURDEN OF PYRUVATE KINASE DEFICIENCY IN THE UNITED STATES

EHA Library, Erin Zagadailov, 324915

'SHEFAA' AN ITP PATIENT ADVOCACY GROUP: AN EGYPTIAN SINGLE CENTER EXPERIENCE

EHA Library, Doaa El Demerdash , 324916

CHRONIC MYELOID LEUKEMIA ACCESS TO TYROSINE KINASE INHIBITORS AND POLYMERASE CHAIN REACTION TESTING IN CENTRAL AND EASTERN EUROPE AND WEST ASIA REGION: A PATIENT ADVOCACY PERSPECTIVE.

EHA Library, Jelena Čugurović, 324917

ADDING AZATHIOPRINE/HYDROXYUREA PRECONDITIONING TO ALEMTUZUMAB/TBI MAY REDUCE RISK OF GRAFT FAILURE IN MATCHED SIBLING DONOR ALLOGENEIC HSCT IN ADULT SICKLE CELL PATIENTS

EHA Library, Elisabeth Dovern, 324918

GBT021601 IMPROVES THE PATHOPHYSIOLOGY OF SICKLE CELL DISEASE IN A MURINE MODEL

EHA Library, Kobina Dufu, 324919

ELIGIBILITY FOR EMERGING THERAPIES IN SICKLE CELL DISEASE

EHA Library, Sona M Vora, 324920

HEMOPEXIN PROTECTS HUMAN ENDOTHELIAL CELLS FROM HEME-DRIVEN ACTIVATION AND DAMAGE IN VITRO

EHA Library, Jacqueline Adam, 324921

SILENT CEREBRAL INFARCTS IN A PEDIATRIC SICKLE CELL DISEASE NATURAL HISTORY COHORT: TOO MANY, TOO SOON?

EHA Library, Raffaella Colombatti, 324922

FT-4202 IMPROVES HEMATOLOGIC AND HEMOLYTIC PARAMETERS IN A PHASE 1 STUDY OF PATIENTS WITH SICKLE CELL DISEASE

EHA Library, Clark Brown, 324923

CYTOKINE MAPPING IN PAEDIATRIC SICKLE CELL DISEASE: ARE DIFFERENT SIGNATURES ASSOCIATED WITH DIFFERENT PHENOTYPES?

EHA Library, Giulia Ceglie, 324924

DISTINCTIVE EFFECTS OF SYSTEMIC IRON RESTRICTION BY FERROPORTIN INHIBITION THROUGH VIT-2763 AND DIETARY IRON LIMITATION IN A SCD MODEL

EHA Library, Giada Ingoglia, 324925

SYSTEMATIC, POINT-OF-CARE NEWBORN SCREENING FOR SICKLE CELL DISEASE IN RURAL MALI, WEST AFRICA

EHA Library, Alan Anderson, 324926

REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR: A MULTICENTER, RETROSPECTIVE STUDY

EHA Library, Biree Andemariam, 324927

ASSOCIATION BETWEEN HOSPITALISED VASO-OCCLUSIVE CRISES AND MORTALITY IN SICKLE CELL DISEASE PATIENTS AGED 16 YEARS AND OLDER USING THE FRENCH NATIONAL HEALTH INSURANCE DATABASE (SNDS)

EHA Library, Jean-Benoît Arlet, 324928

BELGIAN SICKLE CELL DISEASE REGISTRY: DIVERSITY IN PRACTICE BUT LOW MORTALITY

EHA Library, Sarah Wambacq, 324929

REAL-WORLD EXPERIENCE OF VOXELOTOR FOR THE TREATMENT OF PATIENTS WITH SICKLE CELL DISEASE – A SINGLE-CENTER STUDY

EHA Library, Alan Anderson, 324930

PHARMACOKINETIC PROPERTIES OF A HUMAN PLASMA DERIVED HEMOPEXIN DRUG PRODUCT (CSL889) IN TOWNES HBSS-, WILD-TYPE MICE, RATS AND CYNOMOLGUS MONKEYS FOR THE TREATMENT OF ACUTE VOC IN SICKLE CELL DISEASE

EHA Library, Gerald Hoebarth, 324931

REAL-WORLD DATA FROM THE CRIZANLIZUMAB MANAGED ACCESS PROGRAM (MAP): BASELINE DISEASE BURDEN AND PRIOR TREATMENTS FOR PATIENTS WITH SICKLE CELL DISEASE (SCD) AND RECURRENT VASO-OCCLUSIVE CRISES (VOCS)

EHA Library, Ana Cristina Silva-Pinto, 324932

COMPLICATIONS OF SICKLE CELL DISEASE IN EAST LONDON NEWBORN COHORT PATIENTS OVER THE YEARS 2015-2018

EHA Library, Muriel Soriano, 324933

LOW SARS-COV-2 SEROPREVALENCE IN A COHORT OF SICKLE CELL DISEASE (SCD) PATIENTS: POSSIBLE EFFECTS OF EMPHASIS ON SOCIAL ISOLATION FOR A POPULATION INITIALLY CONSIDERED TO BE AT VERY HIGH RISK

EHA Library, Luiza Francisco Trafane, 324934

EVALUATION OF DIFFERENT ESTIMATED GLOMERULAR FILTRATION RATE AS RELIABLE MEASURES OF RENAL FUNCTION IN CHILDREN WITH SICKLE CELL DISEASE

EHA Library, Ilaria Liguoro, 324935

PRECLINICAL SAFETY AND TOXICITY ASSESSMENT OF A HUMAN PLASMA DERIVED HEMOPEXIN DRUG PRODUCT (CSL889) FOR THE TREATMENT OF ACUTE VOC IN SICKLE CELL DISEASE

EHA Library, Tanja Ruthsatz, 324936

ATTITUDES TOWARD THE MANAGEMENT OF SICKLE CELL DISEASE: RESULTS FROM TURKISH REGISTRY

EHA Library, Selma Ünal, 324937

ASSESSING TRANSITION OUTCOMES IN SICKLE CELL DISEASE (SCD) PRIOR TO IMPLEMENTATION OF A FORMAL TRANSITION PROGRAM

EHA Library, Sydney Sheppard, 324938

CHRONIC COMPLICATIONS OF SICKLE CELL DISEASE PATIENTS IN TURKEY

EHA Library, Selma Ünal, 324939

A LONGITUDINAL OBSERVATIONAL STUDY TO EVALUATE THE PSYCHOMETRIC PROPERTIES OF A DAILY DIARY FOR ADOLESCENTS AND ADULTS WITH SICKLE CELL DISEASE

EHA Library, Clark Brown, 324940

ECONOMIC BURDEN OF SICKLE CELL DISEASE IN THE MIDDLE EAST

EHA Library, Hatoon Ezzat, 324941

THE VALUE OF THE YEARS CLINICAL DECISION ALGORITHM TO RULE OUT PULMONARY EMBOLISM IN PATIENTS WITH SICKLE CELL DISEASE: A RETROSPECTIVE EVALUATION.

EHA Library, Aafke Gaartman, 324942

FACTORS ASSOCIATED WITH HOSPITAL ADMISSION DUE TO VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE: RETROSPECTIVE ANALYSIS OF 3-YEAR OBSERVATIONAL STUDY DATA

EHA Library, Matthew Heeney, 324943

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY/RELAPSED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA AFTER ALLOGENEIC CD7-CART CELL THERAPY

EHA Library, Zhihui Li, 324944

PHASE 2 STUDY OF MGTA-145 + PLERIXAFOR FOR RAPID AND RELIABLE HEMATOPOIETIC STEM CELL (HSC) MOBILIZATION FOR AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA

EHA Library, Surbhi Sidana, 324945

FIRST-IN-HUMAN CLINICAL TRIAL OF BCMA-CD19 COMPOUND CAR IN THE REDUCTION OF DONOR-SPECIFIC ANTIBODY IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Fang Liu, 324946

MINIMAL RESIDUAL DISEASE MONITORING AND PREEMPTIVE IMMUNOTHERAPIES FOR FREQUENT 11Q23 REARRANGED ACUTE LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jing Liu, 324947

SURVIVAL TRENDS OF ADULT PATIENTS WITH RELAPSED PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION OVER 20 YEARS: AN ALWP-EBMT ANALYSIS

EHA Library, Ali Bazarbachi, 324948